The dipeptidyl peptidase-4 inhibitor vildagliptin has the capacity to repair β-cell dysfunction andinsulin resistance - Horie, A; Tokuyama, Y; Ishizuka, T; Suzuki, Y; Marumo, K; Oshikiri, K; Ide, K; Sunaga, M; Kanatsuka, A (Horm Metab Res, 2014)